DDR inhibition by pharmacological inhibitors of poly ADP-ribose polymerase (PARP) or checkpoint kinase 1 (CHK1) leads to cytosolic DNA activating the cGAS–STING pathway in SCLC cell lines and tumors [134]. This evidence concerns the gene CHEK1 and small cell lung carcinoma.